A clinical trial of 10.6µm CO2 laser acupuncture treatment for breast cancer related lymphedema

The clinical effect and mechanism of laser acupuncture on breast cancer related lymphedema

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006077

Enrollment

Unknown

Registered

2022-06-07

Start date

2022-07-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer related lymphedema

Interventions

Control group:general treatment

Laser acupuncture group:laser acupuncture treatment

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1)females who had a history of breast cancer;2)had a history of mastectomy with or without adjuvant chemotherapy/ radiotherapy; 3)age over 18 years; 4)mild to moderate lymphedema (2-8 cm increase on the average circumference compared to the unaffected arm).

Exclusion criteria

Exclusion criteria: 1)serious lymphedema, >8 cm increase on the average circumference compared to the unaffected arm); 2)in pregnancy or pregnancy preparation; 3)the upper limb edema was caused by thrombosis or stenosis of the subclavian vein; 4)with a history of chronic inflammatory disease or severe trauma, such as cellulitis of tumor metastasis, venous thrombosis; 5)contraindications for laser radiation, such as photosensitivity disorders, infections, or broken skin;

Design outcomes

Primary

Measure	Time frame
Upper limb circumference;	—

Secondary

Measure	Time frame
Quality of life;Bioelectrical impedance analysis(BIA);	—

Countries

China

Contacts

Public ContactWang Lizhen

wlz@shutcm.edu.cn+86 13817280004

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026